Article Text

Download PDFPDF
Novel insights into immune and inflammatory responses to respiratory viruses
  1. Jürgen Schwarze1,2,
  2. Karen J Mackenzie1
  1. 1MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
  2. 2Child Life and Health, University of Edinburgh, Edinburgh, UK
  1. Correspondence to Dr Jürgen Schwarze, MRC Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; Jurgen.Schwarze{at}


Viral lower respiratory tract infection (LRTI) can lead to severe disease at all ages, but with the exception of influenza vaccination, prevention is not available for most respiratory viruses, hence, effective, disease-limiting therapy is urgently required. To enable the development of novel effective therapeutic approaches, we need to improve understanding of the pathological mechanisms of viral LRTI. Here, we will discuss recently gained new insight into early, innate immune and inflammatory responses to respiratory viruses by airway epithelial cells and mucosal immune cells. Following virus recognition, these cells generate a range of mediators, including innate interferons, proinflammatory cytokines, and growth and differentiation factors which have pivotal roles in effective virus control, and the development of inflammation and disease in viral LRTI.

  • Viral infection
  • Innate Immunity

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles